Treatment of autoimmune diseases by inhibition of T-cell costimulation

David Wofsy, David I. Daikh

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Advances in our understanding of the mechanisms involved in immune activation and immune tolerance have laid the foundation for the development of new strategies for treating autoimmune diseases. In particular, the dissection of the two-signal process of T-cell activation has identified distinct targets that may provide a means of blocking pathological autoimmune responses without causing sustained blockade of protective immune responses. These strategies have shown great promise in animal models for autoimmune diseases, and they are currently the focus of clinical investigation in several autoimmune diseases of humans.

Original languageEnglish (US)
Pages (from-to)1-4
Number of pages4
JournalModern Rheumatology
Issue number1
StatePublished - 2002
Externally publishedYes


  • Autoimmunity
  • CTLA4Ig
  • Costimulation
  • Murine lupus
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Treatment of autoimmune diseases by inhibition of T-cell costimulation'. Together they form a unique fingerprint.

Cite this